Molecular Features Predicting Response/Resistance to Trastuzumab in Metastatic Breast Cancer Patients
NCT00740532
·
clinicaltrials.gov ↗
COMPLETED
Status
11
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
GENETIC:
Gene mutation analyses and FISH
Sponsor
Istituto Clinico Humanitas